Novo Nordisk A/S left open the door for additional work on its pill version of Ozempic for Alzheimer’s disease after a pair ...

Eli Lilly and Novo Nordisk have announced they are working on new oral drugs that can be used for type-2 diabetes and weight ...

Eli Lilly announced trial results for its weight-loss medication, orforglipron, in August. Orforglipron is a once-daily oral ...

Discover the revolutionary needle-free weight-loss pill orforglipron, often referred to as 'Ozempic 2.0'. Learn how it ...

A new pill, Orforglipron, is set to revolutionize weight loss and diabetes treatment. This daily pill, developed by Eli Lilly ...

A first-of-its-kind oral drug boosts muscle metabolism to improve blood sugar and body composition is now headed into larger ...

Novo, which in September said it secured Indian regulatory approval to import and sell Ozempic, on Thursday said it hoped to ...

A new oral GLP-1 receptor agonist, orforglipron, is revolutionizing weight management by offering a needle-free alternative ...

Next-generation pills and monthly injectables promise more choice, fewer side effects and broader health benefits.

The companies that manufacture Ozempic and Mounjaro are set to launch a new weight loss drug that doesn't involve needles.

While the WHO study saw reports of suicidal thoughts were slightly higher for semaglutide in particular, the warning applies ...

A new wave of weight-loss pills, dubbed Ozempic 2.0, promises easier daily dosing, strong results and wider access, with FDA approval expected as early as 2026.